Page 1

Get in Touch: 1-888-253-3960 enquiry@vynzresearch.com

Neurostimulation Device Market

Š 2018 VynZ Research All rights reserved


About VynZ Research… VynZ Research is a global market research firm offering research, analytics, and consulting services on business strategies. We have a recognized trajectory record and our research database is used by many renowned companies and institutions in the world to strategize and revolutionize business opportunities. The company focuses on providing valuable insights on various technology verticals such as Chemicals, Automotive, Transportation, Energy, Consumer Durables, Healthcare, ICT and other emerging technologies. 

VynZ Research has one of the most qualified & experienced analysts, who are constantly tracking the markets and the technologies. The research team has years of proven experience and wide knowledge & understanding of the technology, application, business models, and regulators of the segments and the value chain involved.

A trusted & proven methodology that involves highest quality of primary research, secondary analysis collated & verified through various sources including cross checking with different industry experts.

Serving wide range of customers most of them from Fortune 2000 companies

With a dedicated 24x7 customer helpline our customers can reach for specifying their needs

Developing long term relationship with the clients and satisfying them is one of the crucial notches of the company. VynZ Research aims at gaining and retaining its clients in order to make long term customer relationship.

© 2018 VynZ Research All rights reserved


Neurostimulation Device Market

Industry Overview Neurostimulation device used for deep brain stimulation therapy, This devices are implantable, programmable medical devices that deliver electrical stimulation to specific parts of the patient's brain, spinal cord or peripheral nervous system to helps in the treatment of various conditions, including chronic pain, movement disorders, epilepsy and Parkinson's disease. The neurostimulation device market is expected to grow at 11.2% CAGR during the forecast period with the market size reaching USD 12.2 billion by 2024. Neurostimulation is the technology to deliver low voltage electricity to a specific nerve or target in the spinal cord or brain to affect neuronal transmission. World wide neurostimulation device market is growing at substantial rate due to increasing prevalence of neurological diseases and growing geriatric population. The market has observed high demand for internal neurostimulation over the last few years, due to the increasing prevalence of neurological disorders.

Š 2018 VynZ Research All rights reserved


Neurostimulation Device Market Major factors driving the neurostimulation market include growing target patient population, ongoing product development & commercialization, favorable medical insurance / reimbursements, expansion of healthcare infrastructure, and growing market demand for effective neurovascular devices. Additionally, increasing number of researches in the related field of neurovascular therapies, rising demand for minimally invasive neurosurgical procedures, and increasing awareness among neurosurgeons about minimally invasive surgical procedures provide significant growth opportunities in the market. However, strict regulatory scenario and lack of skilled neurosurgeons may hinder the growth of this market during the forecast period. Geographic Overview Globally, North America is the largest neurostimulation device market as the region has a high dominance of chronic diseases and the increasing geriatric population. As per Centers for Disease Control and Prevention (CDC), in 2015 approximately 23.1 million people in the U.S. had diabetes. According to National Institutes of Health, in the U.S. approximately one million people have Parkinson’s disease. As per the Alzheimer's Association in 2017, 5.5 million Americans had Alzheimer and about 5.3 million of this patient population’s age was 65 years or more. In addition, as per Alzheimer's Association approximately 14 million people are expected to suffer from Alzheimer in 2050. In Asia-Pacific region is observed to witness the fastest growth in the market. Leading population, increasing prevalence of diabetes, growing geriatric population and rising adoption of Š 2018 VynZ Research All rights reserved neurostimulation devices is creating a positive impact on the neurostimulation device market


Neurostimulation Device Market Key players…

Key players in the neurostimulation device industry are investing in the development of innovative and advanced neurostimulation device products, which is strengthening their position in the market. In September 2017, Medtronic, Inc. received FDA approval and launched the Intellis platform for the management of certain types of chronic intractable pain. Medtronic, Inc., Boston Scientific Corporation, Cyberonics, Inc., Nevro Corporation, Neurosigma, Inc., Neuropace, Inc., Coclear Ltd., St. Jude Medical Inc., LivaNova PLC, Aleva Neurotherapeutics SA, Synapse Biomedical, Inc., Neuronetics, Inc. are some of the key players offering neurostimulation devices.

© 2018 VynZ Research All rights reserved


For Sample Report :https://www.vynzresearch.com/healthcare/neurostimulation-device-market/request-sample

www.vynzresearch.com

Š 2018 VynZ Research All rights reserved

Profile for VynZ Research

Neurostimulation Device Market to Witness 11.2% CAGR During Forecast Period (2018–2024)  

The neurostimulation device market is expected to grow at 11.2% CAGR during the forecast period with the market size reaching USD 12.2 billi...

Neurostimulation Device Market to Witness 11.2% CAGR During Forecast Period (2018–2024)  

The neurostimulation device market is expected to grow at 11.2% CAGR during the forecast period with the market size reaching USD 12.2 billi...

Advertisement